A new molecule with anti-cancer and anti-metastatic
properties has been discovered by teams from CNRS, CEA, the Institut Curie and
Inserm(1), in collaboration with Australian and British researchers. This
anticancer drug acts on cells resistant to conventional chemotherapy thanks to
an entirely novel action mechanism. It targets not only the multiplication of
cells but also their mobility and thus could prevent the formation of
metastases. Published in Cancer Research, the results obtained in vitro and on
animals could, in the medium term, lead to the development of alternative
anti-cancer treatments.